Howard Kaufman

Howard Kaufman

Harvard University - Cambridge / United States
Medical and Health Sciences / Immunology
AD Scientific Index ID: 1595336
person_outline Howard Kaufman's MOST POPULAR ARTICLES
1-) Talimogene laherparepvec improves durable response rate in patients with advanced melanomaRHI Andtbacka, HL Kaufman, F Collichio, T Amatruda, N Senzer, ...Journal of clinical oncology 33 (25), 2780-2788, 201521282015
2-) Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working GroupI Puzanov, A Diab, K Abdallah, CO Bingham, C Brogdon, R Dadu, ...Journal for immunotherapy of cancer 5 (1), 1-28, 201712952017
3-) Oncolytic viruses: a new class of immunotherapy drugsHL Kaufman, FJ Kohlhapp, A ZlozaNature reviews Drug discovery 14 (9), 642-662, 201511592015
4-) Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trialHL Kaufman, J Russell, O Hamid, S Bhatia, P Terheyden, SP D\'Angelo, ...The lancet oncology 17 (10), 1374-1385, 201613452016
5-) gp100 peptide vaccine and interleukin-2 in patients with advanced melanomaDJ Schwartzentruber, DH Lawson, JM Richards, RM Conry, DM Miller, ...New England Journal of Medicine 364 (22), 2119-2127, 201111042011